• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

同源和异源五聚体 5-HT3 受体配体识别位点的计算分析。

Computational analysis of ligand recognition sites of homo- and heteropentameric 5-HT3 receptors.

机构信息

Department of Chemistry, University of Modena and Reggio Emilia, Via G. Campi 183, 41100 Modena, Italy.

出版信息

Eur J Med Chem. 2010 Nov;45(11):4746-60. doi: 10.1016/j.ejmech.2010.07.039. Epub 2010 Jul 27.

DOI:10.1016/j.ejmech.2010.07.039
PMID:20724042
Abstract

Inhibition of the 5-hydroxytryptamine receptor (5-HT(3)R), a member of the Cys-loop superfamily of Ligand-Gated Ion Channels (LGICs), has been recognized to have important antiemetic effects. With respect to the many other drugs already in use, such as the first generation 5-HT(3)R antagonist granisetron, palonosetron, a second generation antagonist, clearly demonstrates superior inhibition potency towards the 5-HT(3)Rs. Five different receptor monomers, the 5-HT(3)R A-E, have been identified although the A and B subunits are the only known to build functional receptors, the homopentameric 5-HT(3A)R and the heteropentameric 5-HT(3B-A)R (with BBABA subunit arrangement). At present, however, no three-dimensional structure has been reported for any of the 5-HT(3)R subunits. To understand the binding properties of agonists and antagonists, models of the extracellular portion of the 5-HT(3)R A and B subunits are built and assembled into the receptor (homo- and hetero-) pentameric structure on the basis of the known three-dimensional structure of the nicotinic-acetylcholine receptor (nACh-R). The results of docking studies of the natural agonist serotonin and the antagonists palonosetron and granisetron into the modelled homomeric and heteromeric 5-HT(3)R binding interfaces, provide a possible rationalization both of the higher potency of palonosetron with respect to other antagonists, and of its previously reported allosteric binding and positive cooperativity properties.

摘要

5-羟色胺受体(5-HT(3)R)是配体门控离子通道(LGIC)Cys 环超家族的成员,其抑制作用已被认为具有重要的止吐作用。与已经使用的许多其他药物(如第一代 5-HT(3)R 拮抗剂格拉司琼)相比,第二代拮抗剂帕洛诺司琼对 5-HT(3)R 表现出明显更高的抑制效力。虽然 A 和 B 亚基是唯一已知构建功能性受体的亚基,但已经鉴定出五个不同的受体单体,即 5-HT(3)R A-E。同五聚体 5-HT(3A)R 和异五聚体 5-HT(3B-A)R(具有 BBABA 亚基排列)。然而,目前尚未报道任何 5-HT(3)R 亚基的三维结构。为了了解激动剂和拮抗剂的结合特性,构建了 5-HT(3)R A 和 B 亚基胞外部分的模型,并根据已知的烟碱型乙酰胆碱受体(nACh-R)的三维结构将其组装到受体(同聚体和异聚体)五聚体结构中。将天然激动剂 5-羟色胺和拮抗剂帕洛诺司琼和格拉司琼对接研究的结果进入建模的同聚体和异聚体 5-HT(3)R 结合界面,为帕洛诺司琼相对于其他拮抗剂的更高效力以及其先前报道的变构结合和正协同作用特性提供了一种可能的合理化解释。

相似文献

1
Computational analysis of ligand recognition sites of homo- and heteropentameric 5-HT3 receptors.同源和异源五聚体 5-HT3 受体配体识别位点的计算分析。
Eur J Med Chem. 2010 Nov;45(11):4746-60. doi: 10.1016/j.ejmech.2010.07.039. Epub 2010 Jul 27.
2
Palonosetron exhibits unique molecular interactions with the 5-HT3 receptor.帕洛诺司琼与5-羟色胺3(5-HT3)受体表现出独特的分子相互作用。
Anesth Analg. 2008 Aug;107(2):469-78. doi: 10.1213/ane.0b013e318172fa74.
3
Spatial orientation of the antagonist granisetron in the ligand-binding site of the 5-HT3 receptor.拮抗剂格拉司琼在5-羟色胺3型受体配体结合位点的空间取向。
Mol Pharmacol. 2005 Aug;68(2):365-71. doi: 10.1124/mol.105.011957. Epub 2005 May 24.
4
Interactions of granisetron with an agonist-free 5-HT3A receptor model.格拉司琼与无激动剂的5-HT3A受体模型的相互作用。
Biochemistry. 2006 Jan 31;45(4):1099-105. doi: 10.1021/bi051676f.
5
Characterization of the novel human serotonin receptor subunits 5-HT3C,5-HT3D, and 5-HT3E.新型人类血清素受体亚基5-HT3C、5-HT3D和5-HT3E的特性分析
Mol Pharmacol. 2007 Jul;72(1):8-17. doi: 10.1124/mol.106.032144. Epub 2007 Mar 28.
6
The loop C region of the murine 5-HT3A receptor contributes to the differential actions of 5-hydroxytryptamine and m-chlorophenylbiguanide.小鼠5-HT3A受体的环C区域促成了5-羟色胺和间氯苯双胍的不同作用。
Biochemistry. 2005 Jun 28;44(25):9140-9. doi: 10.1021/bi050661e.
7
The extracellular subunit interface of the 5-HT3 receptors: a computational alanine scanning mutagenesis study.5-HT3 受体的细胞外亚基界面:计算性丙氨酸扫描诱变研究。
J Biomol Struct Dyn. 2012;30(3):280-98. doi: 10.1080/07391102.2012.680029. Epub 2012 Jun 12.
8
A first step towards the understanding of the 5-HT3 receptor subunit heterogeneity from a computational point of view.从计算角度理解 5-HT3 受体亚基异质性的第一步。
Phys Chem Chem Phys. 2012 Sep 28;14(36):12625-36. doi: 10.1039/c2cp41028a. Epub 2012 Aug 9.
9
A comprehensive study on the 5-hydroxytryptamine(3A) receptor binding of agonists serotonin and m-chlorophenylbiguanidine.关于激动剂血清素和间氯苯基双胍对5-羟色胺(3A)受体结合的全面研究。
Bioorg Med Chem. 2009 Aug 15;17(16):5796-805. doi: 10.1016/j.bmc.2009.07.022. Epub 2009 Jul 16.
10
Importance of recognition loops B and D in the activation of human 5-HT₃ receptors by 5-HT and meta-chlorophenylbiguanide.识别环 B 和 D 在 5-HT 和 meta-chlorophenylbiguanide 激活人 5-HT₃ 受体中的重要性。
Neuropharmacology. 2013 Oct;73:398-403. doi: 10.1016/j.neuropharm.2013.06.017. Epub 2013 Jun 26.

引用本文的文献

1
Bivalent Ligands for the Serotonin 5-HT3 Receptor.血清素5-HT3受体的双价配体
ACS Med Chem Lett. 2011 May 9;2(8):571-6. doi: 10.1021/ml2000388. eCollection 2011 Aug 11.
2
Impact of intracellular domain flexibility upon properties of activated human 5-HT3 receptors.细胞内结构域灵活性对活化的人5-羟色胺3型受体特性的影响。
Br J Pharmacol. 2014 Apr;171(7):1617-28. doi: 10.1111/bph.12536.
3
Exploring a potential palonosetron allosteric binding site in the 5-HT(3) receptor.探索 5-HT(3) 受体中帕洛诺司琼的别构结合位点。
Bioorg Med Chem. 2013 Dec 1;21(23):7523-8. doi: 10.1016/j.bmc.2013.09.028. Epub 2013 Sep 20.
4
Approaching the 5-HT₃ receptor heterogeneity by computational studies of the transmembrane and intracellular domains.通过跨膜和细胞内结构域的计算研究探讨 5-HT₃ 受体异质性。
J Comput Aided Mol Des. 2013 Jun;27(6):491-509. doi: 10.1007/s10822-013-9658-2. Epub 2013 Jun 16.
5
Agonists and antagonists induce different palonosetron dissociation rates in 5-HT₃A and 5-HT₃AB receptors.激动剂和拮抗剂在 5-HT₃A 和 5-HT₃AB 受体中诱导不同的帕洛诺司琼解离速率。
Neuropharmacology. 2013 Oct;73:241-6. doi: 10.1016/j.neuropharm.2013.05.010. Epub 2013 Jun 5.
6
Prolonged inhibition of 5-HT₃ receptors by palonosetron results from surface receptor inhibition rather than inducing receptor internalization.帕洛诺司琼对5-HT₃受体的长期抑制是由表面受体抑制引起的,而非诱导受体内化。
Br J Pharmacol. 2013 Jul;169(6):1252-62. doi: 10.1111/bph.12204.
7
Discriminating between 5-HT₃A and 5-HT₃AB receptors.区分 5-HT₃A 和 5-HT₃AB 受体。
Br J Pharmacol. 2013 Jun;169(4):736-47. doi: 10.1111/bph.12166.
8
VUF10166, a novel compound with differing activities at 5-HT₃A and 5-HT₃AB receptors.VUF10166,一种新型化合物,对 5-HT₃A 和 5-HT₃AB 受体具有不同的活性。
J Pharmacol Exp Ther. 2012 May;341(2):350-9. doi: 10.1124/jpet.111.190769. Epub 2012 Feb 3.